Friday, November 22, 2024
HomeTagsFirst Patient Dosed

First Patient Dosed

Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...

Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and other...

Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces the first patient dosed in the Phase II clinical trial of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics